InvestorsHub Logo

biopharm

08/21/17 5:08 PM

#309407 RE: north40000 #309405

In addition, treatment with bavituximab reduced circulating PS-expressing microparticles (exosomes) which are immunosuppressive



I only have taken a little snippet of your post North and this is one example I believe how important Exosomes / various biomarkers that Peregrine developed and still developing, as it helps many Big Pharma understand how valuable these biomarkers can be and especially used as a surrogate endpoint that translates into survival.